Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate appropriators like citizen petition activities

Executive Summary

The Senate Appropriations committee lauds FDA's citizen petition reform activities in the Agriculture spending bill report, and requests the agency provide a report on its citizen petition improvement efforts within 120 days of bill passage. The full committee reported the bill June 22. FDA's report should include "any need for additional funding," the committee states. FDA is examining its petition review process in an attempt to expedite generic drug approvals (1"The Pink Sheet" March 7, 2005, p. 34). In a May report, FDA informed Congress that "many of these citizen petitions might reasonably appear to have been filed in an attempt to delay approval of a generic version of a drug that is not yet subject to generic competition," the committee report states...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel